Phenotyping of CAR T cells.

Adaptive immunotherapy has been growing as a therapeutic alternative for cancer and other diseases treatment; chimeric antigen receptor (CAR) T cells comprise a type of adaptive immunotherapy, with recombinant receptor constructs expressed in T cells to target cells expressing specific antigens, is a potential new treatment for blood cancers and solid tumors. The phenotypic, activation, and functional profile of infused CAR-T cells have been linked to the efficacy of CAR-T cell treatment. As a result, immunophenotypic characterization of CAR-T cells during the bioprocess is critical for controlling cell quality and, eventually, improving antitumor effectiveness. Therefore, we propose a flow cytometry based immunophenotyping analysis of CAR-T cells in this chapter to define the phenotype of CAR-T subsets.

• Publication year

  2022

• Venue

  Methods in Cell Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/bs.mcb.2021.10.001PMID 35152999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunophenotypic Analysis of CAR-T Cells.

  2020cited by this paper
• The Chimeric Antigen Receptor Detection Toolkit

  2020cited by this paper
• A guide to cancer immunotherapy: from T cell basic science to clinical practice

  2020cited by this paper
• Current Status of Gene Engineering Cell Therapeutics

  2018cited by this paper
• CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

  2013cited by this paper
• Targeted immunotherapy of cancer with CAR T cells: achievements and challenges

  2012cited by this paper
• Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.

  2011cited by this paper
• Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy

  2011cited by this paper

• New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies

  2025cites this paper
• An Analysis of Monitoring Solutions for CAR T Cell Production

  2025cites this paper
• Advancement and Challenges in Monitoring of CAR-T Cell Therapy: A Comprehensive Review of Parameters and Markers in Hematological Malignancies

  2024cites this paper